What diagnostics would you perform for Blue?

• A. CT, rhinoscopy, cytology
• B. MRI, rhinoscopy, biopsy
• C. X-ray, rhinoscopy, cytology
• D. CT, biopsy, histopath

Answer: (A)

The question tests choosing a diagnostic plan that combines detailed imaging, direct visualization, and rapid tissue assessment for nasal disease. For Blue, CT is the best first step because it provides clear, cross‑sectional detail of the nasal passages and sinuses, showing bone destruction, extent of disease, and relationships to surrounding structures—information essential for planning any intervention. Following CT, rhinoscopy lets you directly inspect the nasal cavity, identify visible masses or lesions, and obtain targeted samples from specific sites, which increases the chance of a meaningful diagnosis. Obtaining cytology from those samples or from nasal discharge gives rapid, actionable information about what’s causing the problem—whether inflammatory, fungal, bacterial, or neoplastic—without immediately committing to more invasive testing.

While MRI can offer superb soft-tissue detail, especially for brain or deep soft tissues, CT is superior for evaluating bone changes typical of nasal disease and is quicker and more cost-effective. Plain X-ray is far less sensitive in the nasal region and may miss subtle but clinically important findings. Biopsy and histopathology are definitive but more invasive; they’re best reserved for when cytology or imaging indicates a specific concern and a tissue diagnosis is needed to guide treatment.

So, combining CT, rhinoscopy, and cytology provides a comprehensive, efficient, and often minimally invasive approach to accurately diagnose Blue’s nasal condition and plan management.